pharma · Heart Failure · Atrial Fibrillation · RYTM
Rhythm Pharmaceuticals Netherlands
Rhythm Pharmaceuticals Netherlands B.V.
Matisse Pharmaceuticals is a pharma organization headquartered in geleen, NL. It trades on NYSE under ticker RYTM. Primary therapeutic focus areas include Heart Failure, Atrial Fibrillation, Hypothalamic Obesity, Paroxys
BRIGHTLANDS CHEMELOT CAMPUS, VAN ITERSON BUILDING, BURGEMEESTER LEMMENSSTRAAT 352, Geleen, nl HQ
2014 Founded
10 Employees
Public company Type
RYTM · NYSE Ticker
Company details
- Status
- Public
- HQ
- BRIGHTLANDS CHEMELOT CAMPUS, VAN ITERSON BUILDING, BURGEMEESTER LEMMENSSTRAAT 352, Geleen, nl
- Founded
- 2014
- Employees
- 10
- Programs
- 73
- Drugs
- 38
- Patents
- 12
Medtronic Endeavor Resolute
Approved · other · Coronary Artery Disease
Medtronic Endeavor Resolute for Coronary Artery Disease is a Approved program (other) at Rhythm Pharmaceuticals Netherlands B.V. with 1 ClinicalTrials.gov record(s).
Internal code Version 1.2 - IP090
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Rhythm Pharmaceuticals Netherlands B.V.
- Phase
- Approved
- Modality
- other
- Indication
- Coronary Artery Disease
- Status
- completed
- Trials
- 1